Truong Vu 4
4 · Aridis Pharmaceuticals, Inc. · Filed Sep 19, 2023
Insider Transaction Report
Form 4
Truong Vu
DirectorCEO, CSO, Director10% Owner
Transactions
- Award
Stock Options
2023-09-18+30,000→ 817,750 totalExercise: $0.08Exp: 2033-09-18→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]50% of the options vest on the date of grant and 2,500 vest on a monthly basis thereafter for six months.